Caribou Biosciences, Inc. (CRBU) Free cash flow 2019–2025
Caribou Biosciences, Inc. (CRBU) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$112.4MFY2025 · since FY2019: -$32.9M → -$112.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$112.4M | +21.5% |
| FY2024 | -$143.1M | -36.4% |
| FY2023 | -$104.9M | -7.7% |
| FY2022 | -$97.4M | -181.2% |
| FY2021 | -$34.6M | -3.3% |
| FY2020 | -$33.5M | -2.0% |
| FY2019 | -$32.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice